Virus product could kill anthrax and beat antibiotic resistanceAugust 23, 2004Researchers from Rockefeller University, New York, have developed a new way of killing dangerous bacteria like the ones which cause anthrax and pneumonia, using products from a virus, according to new research presented today (Tuesday, 07 September 2004) at the Society for General Microbiology's 155th Meeting at Trinity College Dublin. The new bug-smashing technique uses the bacteria's own natural enemies, tiny viruses called bacteriophages (or phages), which can infect bacterial cells. The phages make thousands of copies of themselves inside infected bacteria, but then need to dissolve the bacteria's cell wall to get out and infect other bacterial cells. "We realised that bacteria have no effective natural defences against these phages once they have been infected," says Professor Vincent Fischetti of Rockefeller University. "After infection, the phages make an enzyme to dissolve the bacterial cell walls for release and we found that we could use the same enzyme to attack and kill the disease bacteria responsible for pneumonia, anthrax or strep throat."
The enzymes work on contact, killing the disease bacteria instantly, but without harming other friendly types of bacteria. This offers huge advantages over conventional antibiotics, which indiscriminately kill most bacteria, including our useful ones, and which can lead to disease resistance building up if used too frequently. "About half of us normally carry disease bacteria in our nose or throat, but without symptoms, which form the only reservoir for these organisms in the environment, allowing them to travel from person to person until they are able to cause infection in the right individual," says Prof Fischetti. "Removing these bacteria from people in hospitals, day care centres and nursing homes could have a major impact on disease outbreaks amongst vulnerable people in these settings." The novel technique offers medical workers an opportunity to control disease bacteria in a completely new way. So far no resistance has been found to the enzymes, but if it were to occur it would be very rare, much rarer than antibiotic resistance. The enzymes successfully kill antibiotic-resistant bacteria that are causing a major problem in hospitals and nursing homes. "We now have enzymes that kill all bacteria of a particular type, called Gram-positive bacteria, of the major disease-causing organisms, including bacteria for strep throat, pneumonia, neonatal meningitis, endocarditis and anthrax," says Prof Fischetti. "Since we have never found any resistance to the enzymes, they can be used safely, long term, even to kill recurrent infections." In addition, the scientists are currently carrying out clinical trials of an enzyme which can specifically kill anthrax in the blood. This could be used during a terrorist attack or emergency to save the lives of exposed individuals. Society for General Microbiology | |||||||||||||||||||||
|
Related Anthrax News Articles Green catalysts provide promise for cleaning toxins and pollutants Tetra-Amido Macrocyclic Ligands (TAMLs) are environmentally friendly catalysts with a host of applications for reducing and cleaning up pollutants, and a prime example of "green chemistry." Carnegie Mellon University's Terry Collins, the catalyst's inventor, believes that the small-molecule catalysts have the potential to be even more effective than previously proven. Nano vaccine for hepatitis B shows promise for third world Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. Francisella tularensis: Stopping a biological weapon Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently we knew very little about this bacterium. Effective health messages may yield vaccine compliance among ER workers Emergency room workers will be the first line of defense in the event of a disease pandemic and will be forced to deal with the chaos that inevitably comes with treating thousands of sick and dying. In order to protect themselves and allow them to care for the public, these first responders need to be fully prepared by getting available vaccines now. Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances Security and law enforcement officials may some day have a new ally - a universal detection system that can monitor the air for virtually all of the major threat agents that could be used by terrorists. New strategies against bird flu The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). NIST, Army researchers pave the way for anthrax spore standards Researchers from the National Institute of Standards and Technology (NIST) and the U.S. Army Dugway (Utah) Proving Ground have developed reliable methods based on DNA analysis to assess the concentration and viability of anthrax spores after prolonged storage. Protein data bank archives 50,000th molecule structure The Protein Data Bank (PDB) based at Rutgers, The State University of New Jersey, and the University of California-San Diego (UCSD) this month reached a significant milestone in its 37-year history. The 50,000th molecule structure was released into its archive, joining other structures vital to pharmacology, bioinformatics and education. Biosensing nanodevice to revolutionize health screenings One day soon a biosensing nanodevice developed by Arizona State University researcher Wayne Frasch may eliminate long lines at airport security checkpoints and revolutionize health screenings for diseases like anthrax, cancer and antibiotic resistant Staphylococcus aureus (MRSA). Is a cup of tea really the answer to everything -- even anthrax? A cup of black tea could be the next line of defence in the threat of bio-terrorism according to new international research. More Anthrax News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||